Cargando…
VWF, Platelets and the Antiphospholipid Syndrome
The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with the persistent presence of antiphospholipid antibodies (aPLs). Laboratory criteria for the classification of APS include the detection of lupus anticoagulant (LAC), anti-cardiolipin (aCL) antibodies an...
Autores principales: | Huang, Shengshi, Ninivaggi, Marisa, Chayoua, Walid, de Laat, Bas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074042/ https://www.ncbi.nlm.nih.gov/pubmed/33919627 http://dx.doi.org/10.3390/ijms22084200 |
Ejemplares similares
-
Brief Report on the 11th Meeting of the European Forum on Antiphospholipid Antibodies
por: Chayouâ, Walid, et al.
Publicado: (2019) -
Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?
por: Chayoua, Walid, et al.
Publicado: (2021) -
Abacavir use is associated with increased prothrombin conversion
por: Yan, Qiuting, et al.
Publicado: (2023) -
ST Genesia reference values of 117 healthy donors measured with STG‐BleedScreen, STG‐DrugScreen and STG‐ThromboScreen reagents
por: Ninivaggi, Marisa, et al.
Publicado: (2020) -
Assessing the individual roles of FII, FV, and FX activity in the thrombin generation process
por: Bai, Cuicui, et al.
Publicado: (2022)